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Received February 17, 2016; accepted March 3, 2016AbstractPrior to 2015, Zika Virus (ZIKV) outbreaks had occurred in areas of Africa, Southeast Asia, and the Pacific Islands. Although a causal
relationship between Zika infection during pregnancy and microcephaly is strongly suspected, such a connection has not yet been scientifically
proven. In May 2015, the outbreak of ZIKV infection in Brazil led to reports of syndrome and pregnant women giving birth to babies with birth
defects and poor pregnancy outcomes; the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed ZIKV
infection in Brazil. Currently, ZIKV outbreaks are ongoing and it will be difficult to predict how the virus will spread over time. ZIKV is
transmitted to humans primarily through the bite of infected mosquitos, Aedes aegypti and Aedes albopictus. These mosquitoes are the principle
vectors of dengue, and ZIKV disease generally is reported to include symptoms associated with acute febrile illnesses that clinically resembles
dengue fever. The laboratory diagnosis can be performed by using reverse-transcriptase polymerase chain reaction (RT-PCR) on serum, viral
nucleic acid and virus-specific immunoglobulin M. There is currently no vaccine and antiviral treatment available for ZIKV infection, and the
only way to prevent congenital ZIKV infection is to prevent maternal infection. In February 2016, the Taiwan Centers for Disease Control
(Taiwan CDC) activated ZIKV as a Category V Notifiable Infectious Disease similar to Ebola virus disease and MERS.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Zika virus (ZIKV) is a single-stranded RNA virus, an
arthropod-borne flavivirus distributed throughout much of
Africa and Asia. Other mosquito-borne flaviviruses previously
determined to be of public health importance include yellow
fever, dengue, St. Louis encephalitis, West Nile and Japanese
encephalitis viruses. ZIKV is transmitted to humans primarily
through the bite of an infected Aedes mosquito species, first
isolated from a monkey in the Zika forest of Uganda in 1947.1
Subsequently, sporadic human infections were reported in
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).reported from Yap State, Federated States of Micronesia in
2007.2 The Asian lineage of the virus reappeared in French
Polynesia in October 2013, and thereafter between November
2013 and February 2014, with an increased incidence of
neurological complications, including 42 cases of Guillain-
Barre syndrome; these complications were a unique and
worrisome feature of the outbreak that warrants further study.3
ZIKV disease is generally reported with characteristics of
acute febrile illnesses that clinically resembles dengue fever.
The most common symptoms are fever, joint pain, rashes, and
conjunctivitis, with symptoms lasting from several days to a
week.2. Countries with current active Zika virus infection
As of February 4, 2016, the ZIKV epidemic has continued
to spread in most of the countries where its presence wassevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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reported from 31 countries within the past 2 months, and 36
countries in the past 9 months.4 Ultimately, ZIKV may be
spread globally into additional environments where mosquitos
can live and breed. The geographical range of ZIKV infection
has increased in 2015 and 2016, with 26 countries and terri-
tories in the Americas now reporting autochthonous trans-
mission of ZIKV.5
3. Mode of transmission
ZIKV is transmitted to humans primarily through the bite of
infected mosquitos, namely: Aedes aegypti and Aedes albo-
pictus), which are found throughout much of the Americas,
including part of the United States. These mosquitoes are the
principle vectors of dengue, chikungunya, Zika, and yellow
fever.6,7 These vectors are aggressive day time biters that
breed in domestic water holding containers, and feed primarily
in the outdoors and indoors near dwellings. During the out-
breaks, anthroponotic (human-to-vector-to-human) trans-
mission can occur. Mosquitoes become infected when they
bite a person already infected with the virus. Infected
mosquitoes can then spread the virus to other people through
bites. To date, infected ZIKV RNA has been detected in blood,
urine, semen, saliva, cerebrospinal fluid, amniotic fluid, and
breast milk. Regarding transmission of the virus through the
mother and to her baby during pregnancy, blood transfusion
and sexual contact have been reported; however, there is
currently no evidence that the virus is transmitted to babies
through breast feeding.7e10 However, the mechanism by
which some mothers can pass the virus to their babies is still
under study.
4. Clinical signs and symptoms
Signs and symptoms of ZIKV infection are relatively mild.
Although the illness develops in only one in five persons,
severe disease requiring hospitalization is uncommon and case
fatality is very low.11 The symptoms typically occur approx-
imately 2 to 12 days after the mosquito bite, presenting most
commonly with fever, maculopapular rash, conjunctivitis, and
joint pain, and the clinical illness lasts for several days to a
week. Other symptoms include muscle pain and headache, but
abdominal pain, nausea, diarrhea, mucus membrane ulcera-
tions, and pruritus are rarely observed.12 There is a possible
association between ZIKV and microcephaly in newborn ba-
bies with maternal ZIKV infection,4,13 and some infected
adults with neurologic conditions like Guillain-Barre syn-
drome (GBS) were also reported.14 By the first week of
February, 2016, 4783 suspected cases of microcephaly have
been reported in Brazil; of these cases, 1132 (24%) were
investigated and classified. If was found that 404/1132 (36%)
cases had confirmed microcephaly and/or central nervous
system malformations, and 17/404 (4%) were positive for
ZIKV infection.4 In July 2015, Brazil reported 76 cases with
ZIKV infection with neurologic syndromes in Bahia state, and
42 of those cases were confirmed to have GBS.5 In lateJanuary 2016, 104, 2, 1, and 255 cases of GBS were reported
from El Salvador, Martinique, New Zealand, and Venezuela,
respectively. French Polynesia also reported one imported case
of ZIKV with neurological symptoms in February 2016.4
Some countries, including Colombia and Suriname, reported
ZIKV infection with deaths involving GBS or chronic medical
illness.15
5. Diagnosis
The primary diagnosis of ZIKV infection is based on the
patient's typical clinical features, places and dates of travel and
activities. During the first week after onset of symptoms,
laboratory diagnosis can be performed by using reverse-
transcriptase polymerase chain reaction (RT-PCR) on serum
or plasma to detect virus, viral nucleic acid,16 or virus-specific
immunoglobulin M and neutralizing antibodies.17,18 During
the acute illness period of ZIKV infection in patients, symp-
toms such as fever, rash, conjunctivitis, and serological testing
can confirm the presence of ZIKV virus. However, there are no
good laboratory tools with the capacity to confirm what occurs
during the other months. Cross-reaction with some related
flaviviruses, such as dengue 1,2,3, and 4, and with yellow fever
and West Nile viruses is common, creating a circumstance
where proper diagnosis of ZIKV may be difficult to achieve.19
Then, a plaque-reduction neutralization testing can be per-
formed to measure virus-specific neutralizing antibodies and
differentiate between cross-reacting antibodies in primary
flavivirus infections.17,18 Due to a routine cross-reaction that is
common in patients with dengue virus, patients with ZIKV
infection should be evaluated for possible dengue virus
infection. Dengue virus infection usually presents with high
fever, severe headache, pain behind the eyes, muscle and joint
pains, nausea, vomiting, swollen glands or rash. Dengue fever
usually occurs after an incubation period of 4-10 days after the
bite of the infected mosquito, and symptoms usually last for
2e7 days.20 Unlike ZIKV infection, dengue typically is not
associated with conjunctivitis (Table 1).
6. Management and Prevention of Zika virus infection
There is presently no vaccine and no specific antiviral
treatment for ZIKV infection. Treatment is often supportive,
and symptoms can be generally treated with fluids, rest and
oral analgesics and antipyretics (e.g., acetaminophen) for fever
and pain relief, while aspirin and others nonsteroidal anti-
inflammatory drugs (NSAIDs) should be used only when
dengue has been ruled out because of the risk of bleeding.21
However, NSAIDs are not typically used during pregnancy.22
7. Prevention of mosquito bite
During the first week of ZIKV infection, the infected pa-
tient should avoid further mosquito bite because the ZIKV can
be found in the blood and pass from an infected person to a
mosquito. Consequently, an infected mosquito can then spread
the virus to another person. Preventing further mosquito bite
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sleeved shirts and long pants, and treating clothing with
permethrin. However, insect repellent should not be used on
babies younger than 2 months of age. An infected female
mosquito lays several hundred eggs on the wall of the water
filled containers. Therefore, it is important to eliminate
standing water in and outside of the home by emptying,
washing and scrubbing thoroughly, and then tightly covering
water storage containers (buckets, cisterns, rain barrels) once a
week so that mosquitoes cannot get inside to lay eggs.23
8. Vaccine development
Effective vaccines exist for several flaviviruses, such as
yellow fever virus, Japanese encephalitis, and tick-borne en-
cephalitis. These vaccines were introduced in the 1930s, while
the vaccine for dengue fever only became available for use in
the mid-2010s.24,25 Recently, the Indian Bharat Biotech In-
ternational company reported that it has two ZIKV vaccine
candidates that will be entering pre-clinical trials in animal
and commenced in late February 2016.26
9. For travelers
Travelers visiting countries where the ZIKV virus is active
should use individual protective measures to avoid mosquito
bites. Such protective measures include using repellent,
wearing long-sleeved shirts and long trousers, and utilizing
mosquito nets when sleeping even during daytime hours.
There is evidence that the ZIKV can be sexually transmitted
from a man to his sexual partners. Therefore, men who resideTable 1
Differential diagnosis of Zika virus infection vs Dengue fever.
Zika virus
infection
Dengue fever
Vector Aedes aegypti,
Aedes albopictus
Aedes aegypti, Aedes
albopictus
Signs and
symptoms
Mild fever,
conjunctivitis,
rash, muscle and
joint pain
High fever, severe muscle
and joint pain, severe
headache, retro-orbital
pain, rash, mild bleeding
Maternal-fetus
transmission
Fetal
microcephaly,
intracranial
calcification
Still birth, low birth
weight, and premature
birth
Geographic
distribution
Africa, Southeast
Asia, and the
Pacific Island;
currently outbreak
Americas
Tropics and subtropics,
endemic in at least 100
countries in Asia, the
Pacific, the Americas,
Africa, and the Caribbean
Onset time 2 to 12 days 3 to 8 days (14 days
longer)
Management Supportive Supportive
Prevention Environmental
and Vector
control, no
vaccine, vaccine
could take years
Environmental and Vector
control, no vaccine,
vaccine could be
available in 2016.in or have traveled to an area of active ZIKV transmission
should abstain from sexual activity, or consistently and
correctly use condoms when having sex within 2 weeks after
he returns, and postpone giving blood for at least 28 days to
prevent ZIKV transmission.27 Due to potential risks of ZIKV
infection by sexual transmission in women of reproductive
age (15-44 years), the CDC has recommended that health
care providers should discuss and provide counseling about
reproductive screening, testing and pregnancy planning in
those women residing in areas with ongoing ZIKV
infection.28
10. For pregnant women
The Centers for Disease Control and Prevention (CDC) has
recommended that women who are pregnant or plan to
become pregnant in the near term consider delaying travel to
areas with active Zika virus. Pregnant women residing in or
traveling to areas of active ZIKV transmission should take
steps to prevent ZIKV infection through prevention of mos-
quito bites, including use of insect repellant. For those preg-
nant women who have recently traveled to Zika-infected areas,
they should consult with their healthcare provider even if they
don't feel any symptoms of the disease.12,27
11. Management and prevention of congenital Zika virus
infections
To date, there is no vaccine and antiviral treatment avail-
able for ZIKV infection, and the only way to prevent
congenital ZIKV infection is to prevent maternal infection.
The CDC recommended that serologic testing be offered to
asymptomatic pregnant women 2-12 weeks after returns from
areas with ongoing ZIKV transmission. For asymptomatic
pregnant women who are residing in areas with ongoing ZIKV
transmission, Serological testing should be performed at the
first prenatal care visit, and then followed-up in the mid-
second trimester to prevent ongoing risk of transmission for
women throughout their pregnancies. For symptomatic preg-
nant women, the CDC has recommended testing during the
first week of illness.28 Treatment of congenital ZIKV infection
is supportive and should take into consideration specific
medical and neurodevelopmental concerns for the infant's in-
dividual needs. No evidence has been found indicating that
ZIKV infection can be transmitted through breast milk, and
recommendations may even continue to suggest that women
breastfeed infants even in areas with ZIKV found.29
12. Zika virus infection and Congenital Microcephaly
Microcephaly is a condition where a baby's head is char-
acteristically much smaller than expected compared to babies
of the same gestational age and sex. Infants with microcephaly
can have a range of problems such as neurological sequelae,
seizure, problems with movement and balance, intellectual
disability, vision or hearing problems, and developmental
problems such as speech, delay milestones like sitting,
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mild to the severe, and may have lifetime consequences for
infected patients.30,31 In early 2015, ZIKV infections were first
confirmed in babies with microcephaly in Brazil, and the
incidence of microcephaly in fetuses born to mothers with
ZIKV infection continues to increase. This possible connec-
tion between ZIKV infection and microcephaly in babies
represents a substantial public health concern. And apart from
microcephaly, other brain abnormalities that disrupt brain
growth32 such as intracranial calcifications, ventriculomegaly,
and neuronal migration disorders (lissencephaly and pachy-
gyria) may also be found to have some potential involvement
in or vulnerability to ZIKV infection. Recently, Mlakar et al.
reported on a case of severe fetal brain injury associated with
ZIKV infection with vertical transmission. Pathological find-
ings of the fetal brain showed complete agyria, hydrocephalus,
multifocal dystrophic calcifications in the cortex and subcor-
tical white matter, with associated cortical displacement and
mild focal inflammation. ZIKV was detected on RT-PCR assay
from the fetal brain; however, neither ZIKV nor pathological
changes were detected in any other fetal organs, which sug-
gests a strong relationship between ZIKV and neurological
damage.33
In conclusion, there appears to be significant evidence
suggesting that Zika is the cause of microcephaly which can
lead to severe neurological sequelae in babies. The WHO
declared ZIKV infection to be an international public health
emergency in early February 2016. However, there has been
no significant increase in the number of microcephaly cases in
Taiwan. In Taiwan, only one imported case of ZIKV infection
was reported on January 10, 2016, and no other cases have
been identified. Recently, China also has reported a case, a 39-
year-old male who returned to China from Venezuela. The
Taiwan CDC advised women who were pregnant or who
planned to become pregnant to postpone travel to Zika-
affected areas of ongoing local outbreaks.15 ZIKV infection
has continued to spread worldwide, especially in Latin
America and the Caribbean region, and Taiwan's CDC has
issued travel notices and published guidelines for preventive
measures, listing ZIKV infection as a Category V Notifiable
Infectious diseases and closely monitored ZIKV importation,
border quarantine and vector control in preparation for
occurrence of local Zika outbreaks.34
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